| Literature DB >> 25980672 |
Ho-Sung Lee1, Myeong-Jin Goh2, Junil Kim3, Tae-Jun Choi3, Hae Kwang Lee2, Yong Joo Na2, Kwang-Hyun Cho1.
Abstract
Melanogenesis is the process of melanin synthesis through keratinocytes-melanocytes interaction, which is triggered by the damaging effect of ultraviolet-B (UVB) rays. It is known that melanogenesis influences diverse cellular responses, including cell survival and apoptosis, via complex mechanisms of feedback and crosstalk. Therefore, an attempt to suppress melanin production by modulating the melanogenesis pathway may induce perturbations in the apoptotic balance of the cells in response to UVB irradiation, which results in various skin diseases such as melasma, vitiligo, and skin cancer. To identify such appropriate target strategies for the reduction of UVB-induced melanin synthesis, we reconstructed the melanogenesis signaling network and developed a Boolean network model. Mathematical simulations of the melanogenesis network model revealed that the inhibition of beta-catenin in the melanocytes effectively reduce melanin production while having minimal influence on the apoptotic balance of the cells. Exposing cells to a beta-catenin inhibitor decreased pigmentation but did not significantly change the B-cell Chronic lymphocytic leukemia/lymphoma 2 expression, a potent regulator of apoptotic balance. Thus, our systems analysis suggests that the inhibition of beta-catenin may be the most appropriate target strategy for the reduction of UVB-induced skin pigmentation.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25980672 PMCID: PMC4434836 DOI: 10.1038/srep10305
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1A schematic diagram of the melanogenesis network. The melanogenesis network comprises two major signaling modules: the keratinocytes (red square) and the melanocytes (blue square) modules. The network consists of 62 nodes and 113 links; 80 links are activating (pointed arrows) and 33 are inhibiting (blunted arrows). Among the 62 nodes, there are one external-input node (UVB) and three output nodes (melanin, Bcl-2 in the keratinocytes, and Bcl-2 in the melanocytes) (see Supplementary Materials). IL-1, interleukin 1; PTEN, phosphatase and tensin homolog; EGFR, epidermal growth factor receptor; PI3K, phosphatidylinositol 3-kinase; ASK1, apoptosis signal-regulating kinase 1; SG, the growth factor receptor–bound protein 2 (Grb2) and Son of Sevenless (SOS) complex; PDK1, phosphoinositide-dependent kinase 1; MKK6, mitogen-activated protein kinase (MAPK) 6; MKK4, mitogen-activated protein kinase (MAPK) 4; JNK, c-Jun N-terminal kinase; GSK3b, Glycogen synthase kinase-3 beta; b-catenin, beta-catenin; ERK, extracellular signal-regulated kinase; MEK, MAPK/ERK kinase; MDM2, mouse double minute 2 homolog; NFAT, nuclear factor of activated T-cells; COX-2, cyclooxygenase-2; RSK, ribosomal s6 kinase; ETR, endothelin receptor; MC1R, melanocortin 1 receptor; EP4, prostaglandin E receptor 4; PKC, protein kinase C; AC, adenylyl cyclase; cAMP, cyclic adenosine monophosphate; PKA, protein kinase A; PDE, phosphodiesterase; MSK, mitogen- and stress-activated kinase and CREB, cAMP response element-binding protein.
Figure 2Qualitative, individual input–output relationships in the Boolean model of melanogenesis network. ‘K’ denotes the nodes of keratinocytes and ‘M’ denotes the nodes of melanocytes. (A) Positive relationship between UVB and Akt_K activation22. Positive relationship between UVB and beta-catenin_K expression23. (C) Positive relationship between UVB and COX-2_K expression24. (D) Positive relationship between UVB and EGFR activation_K25. (E) Positive relationship between UVB and ET-1_K expression26. (F) Positive relationship between UVB and IL-1_K expression27. (G) Positive relationship between UVB and JNK_K activation28. (H) Positive relationship between UVB and NFAT_K activation29. (I) Positive relationship between UVB and PGE2_K activation30. (J) Positive relationship between UVB and PI3K_K activation31. (K) Negative relationship between UVB and PTEN_K activation22. (L) Positive relationship between UVB and Ras_K activation32. (M) Positive relationship between UVB and SCF_K activation33. (N) Positive relationship between UVB and cAMP_M activation34. (O) Positive relationship between UVB and c-kit_M activation35. (P) Positive relationship between UVB and induction of MITFmRNA_M2. (P) Positive relationship between UVB and induction of MITFprotein_M2 (R) Positive relationship between UVB and PKA_M activation36. (S) Positive relationship between UVB and melanin synthesis3738. (T) Negative relationship between UVB and Bcl-2_K expression3940. Note that the dose–response curves presented here are intended to demonstrate how the melanogenesis network model qualitatively reproduces the referenced input–output relationships over a wide range of input signal. The simulations were performed repetitively (n = 10) at 2% noise to the input (see Materials and Methods).
Potentially effective target strategies for the reduction of UVB-induced skin pigmentation.
| Node | Perturbation | Δ Melanin (%) | Δ Bcl-2_K (%) | Δ Bcl-2_M (%) |
|---|---|---|---|---|
| b-catenin_M | Inhibition | −100.00 | 7.78 | −8.15 |
| MITFmRNA_M | Inhibition | −100.00 | 7.78 | −23.75 |
| MITFprotein_M | Inhibition | −100.00 | 7.78 | −23.75 |
| GSK3b_M | Constitutive activation | −100.00 | 7.78 | −23.95 |
| ERK_M | Inhibition | −100.00 | 7.78 | −58.53 |
| MEK_M | Inhibition | −100.00 | 7.78 | −58.53 |
| RAF_M | Inhibition | −100.00 | 7.78 | −58.53 |
| CREB_M | Inhibition | −100.00 | 7.78 | −86.62 |
| Akt_M | Inhibition | −100.00 | 7.78 | −100.00 |
| PDK1_M | Inhibition | −100.00 | 7.78 | −100.00 |
| PI3K_M | Inhibition | −100.00 | 7.78 | −100.00 |
| cAMP_M | Constitutive activation | −100.00 | 7.78 | −100.00 |
| MKK6_M | Constitutive activation | −100.00 | 7.78 | −100.00 |
| p38_M | Constitutive activation | −100.00 | 7.78 | −100.00 |
| ASK1_M | Constitutive activation | −100.00 | 7.78 | −100.00 |
The list comprises node controls that significantly reduce (<–90%) the activity of node ‘melanin’ in response to UVB irradiation.
Figure 3Network behavior in response to potentially effective target strategies under UVB irradiation. Fraction of initial states evolving into pigmentation, keratinocytes survival, or melanocytes survival attractors (phenotypes) in response to potentially effective target strategies under UVB irradiation.
Figure 4Effects of inhibition of beta-catenin or CREB on the UVB-induced skin pigmentation and Bcl-2 expression. (A) Graphs of the ΔL value of the UVB-irradiated skin equivalent model, MelanoDermsTM, exposed to the indicated concentrations of IWP-2 (an inhibitor of Wnt/beta-catenin pathway) or 217505 (a CBP-CREB interaction inhibitor). 1% kojic (70.37 mM) acid was used as a positive control. MelanoDermsTM were grown at the air-liquid interface and the maintenance medium was replenished every 2 days. After a 9-day of exposure to the chemicals, pigmentation of the skin equivalent was assessed by comparing the change in L* value, a value of CIE 1976 (L*,a*,b*) color space representing the brightness. (B and C) Graphs of the Bcl-2 expression level and the cell viability in normal human keratinocytes and normal human melanocytes exposed to IWP-2 [+, 10 μM; ++, 20 μM] or 217505 [+, 12.5 μM; ++, 25 μM] with or without UVB irradiation. Cells were cultured in 6-well plate and exposed to UVB irradiation (10 mJ/cm2). The cells were then treated with IWP-2 or 217505 for 24 hours. After incubation, the cells were harvested and lysed. Bcl-2 expression level was measured by using human Bcl-2 ELISA kit (Abcam, Cambridge, U.K.). For the cell viability assay, the cells were treated with WST-1 (Roche Molecular Biochemicals, Mannheim, Germany). Cell viability was determined from absorbance (OD 450) measured by using microplate reader. Data represent the means + SD of three biological replicates. P-values were determined by Student’s t test; P < 0.05 was considered statistically significant. No statistically significant difference in the Bcl-2 expression level or the cell viability was observed between control and IWP-2 treated cells upon UVB irradiation (P > 0.05).